Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026)

Regeneron Pharmaceuticals (REGN) posted quarterly Dividends Paid - Common of $96.8 million for Q2 2026, up 4.54% year-over-year from $92.6 million in Q2 2025, and down 1.02% quarter-over-quarter from $97.8 million in Q1 2026.

Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026) Analysis & Trends

Regeneron Pharmaceuticals' Dividends Paid - Common history runs 2 years deep, the most recent figure standing at $96.8 million for Q2 2026.

  • In Q2 2026, Dividends Paid - Common rose 4.54% year-over-year to $96.8 million; the TTM figure through Jun 2026 stood at $378.5 million (up 103.06% YoY), while the FY2025 annual figure was $370.3 million, changed N/A from the prior year.
  • Dividends Paid - Common for Q2 2026 stood at $96.8 million, down from $97.8 million in the prior quarter.
  • The five-year high for Dividends Paid - Common was $97.8 million in Q1 2026, with the low at $91.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 96.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 34.60 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 96.80 Mn
Jun 30, 2026 96.80 Mn
Mar 31, 2026 97.80 Mn
Mar 31, 2026 97.80 Mn
Dec 31, 2025 92.70 Mn
Dec 31, 2025 92.70 Mn
Sep 30, 2025 91.20 Mn
Sep 30, 2025 91.20 Mn
Jun 30, 2025 92.60 Mn
Jun 30, 2025 92.60 Mn
Mar 31, 2025 93.80 Mn
Mar 31, 2025 93.80 Mn